BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 16455244)

  • 1. Synthesis of constrained ceramide analogs and their potent antileukemic activities.
    Ha HJ; Hong MC; Ko SW; Kim YW; Lee WK; Park J
    Bioorg Med Chem Lett; 2006 Apr; 16(7):1880-3. PubMed ID: 16455244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3,4-Disubstituted oxazolidin-2-ones as constrained ceramide analogs with anticancer activities.
    Singh A; Ha HJ; Park J; Kim JH; Lee WK
    Bioorg Med Chem; 2011 Nov; 19(21):6174-81. PubMed ID: 21978949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and potent antileukemic activities of N-lactylsphingosine and N-lactyldihydrosphingosine.
    Azuma H; Takao R; Shikata K; Niiro H; Tachibana T; Ogino K
    J Med Chem; 2003 Jul; 46(16):3445-7. PubMed ID: 12877580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MZ3 induces apoptosis in human leukemia cells.
    Fang L; He Q; Hu Y; Yang B
    Cancer Chemother Pharmacol; 2007 Feb; 59(3):397-405. PubMed ID: 16900371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation, structure elucidation, total synthesis, and evaluation of new natural and synthetic ceramides on human SK-MEL-1 melanoma cells.
    León F; Brouard I; Rivera A; Torres F; Rubio S; Quintana J; Estévez F; Bermejo J
    J Med Chem; 2006 Sep; 49(19):5830-9. PubMed ID: 16970407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptotic activities of C2-ceramide and C2-dihydroceramide homologues against HL-60 cells.
    Shikata K; Niiro H; Azuma H; Ogino K; Tachibana T
    Bioorg Med Chem; 2003 Jul; 11(13):2723-8. PubMed ID: 12788346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of a novel ceramide analogue via Tebbe methylenation and evaluation of its antiproliferative activity.
    Lu X; Arthur G; Bittman R
    Org Lett; 2005 Apr; 7(8):1645-8. PubMed ID: 15816773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of 7-oxasphingosine and -ceramide analogues and their evaluation in a model for apoptosis.
    Rajan R; Wallimann K; Vasella A; Pace D; Genazzani AA; Canonico PL; Condorelli F
    Chem Biodivers; 2004 Nov; 1(11):1785-99. PubMed ID: 17191816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of ceramide metabolism in T-leukemia cell lines potentiates apoptosis induced by the cationic antimicrobial peptide bovine lactoferricin.
    Furlong SJ; Ridgway ND; Hoskin DW
    Int J Oncol; 2008 Mar; 32(3):537-44. PubMed ID: 18292930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancing effects of ceramide derivatives on 1,25-dihydroxyvitamin D(3)-induced differentiation of human HL-60 leukemia cells.
    Kim DS; Kim SH; Song JH; Chang YT; Hwang SY; Kim TS
    Life Sci; 2007 Dec; 81(25-26):1638-44. PubMed ID: 18031762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of apoptotic cell death by a ceramide analog in PC-3 prostate cancer cells.
    Oh JE; So KS; Lim SJ; Kim MY
    Arch Pharm Res; 2006 Dec; 29(12):1140-6. PubMed ID: 17225464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceramide-induced cell death in lens epithelial cells.
    Samadi A
    Mol Vis; 2007 Sep; 13():1618-26. PubMed ID: 17893663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiproliferation and apoptosis induced by C-glycosides in human leukemia cancer cells.
    Sanhueza CA; Mayato C; García-Chicano M; Díaz-Peñate R; Dorta RL; Vázquez JT
    Bioorg Med Chem Lett; 2006 Aug; 16(16):4223-7. PubMed ID: 16765045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactoferricin-induced apoptosis in estrogen-nonresponsive MDA-MB-435 breast cancer cells is enhanced by C6 ceramide or tamoxifen.
    Furlong SJ; Mader JS; Hoskin DW
    Oncol Rep; 2006 May; 15(5):1385-90. PubMed ID: 16596215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic activity of selected trifluoromethyl ketones against oral tumor cells.
    Ideo A; Sasaki M; Nakamura C; Mori K; Shimada J; Kanda Y; Kunii S; Kawase M; Sakagami H
    Anticancer Res; 2006; 26(6B):4335-41. PubMed ID: 17201152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of furopyrazole analogs of 1-benzyl-3-(5-hydroxymethyl-2-furyl)indazole (YC-1) as novel anti-leukemia agents.
    Chou LC; Huang LJ; Yang JS; Lee FY; Teng CM; Kuo SC
    Bioorg Med Chem; 2007 Feb; 15(4):1732-40. PubMed ID: 17189698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and biological activity of a family of novel ceramide analogues in chemoresistant breast cancer cells.
    Antoon JW; Liu J; Gestaut MM; Burow ME; Beckman BS; Foroozesh M
    J Med Chem; 2009 Sep; 52(18):5748-52. PubMed ID: 19694470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The synthesis of 18beta-glycyrrhetinic acid derivatives which have increased antiproliferative and apoptotic effects in leukemia cells.
    Liu D; Song D; Guo G; Wang R; Lv J; Jing Y; Zhao L
    Bioorg Med Chem; 2007 Aug; 15(16):5432-9. PubMed ID: 17566745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-proliferation, cell cycle arrest and apoptosis induced by a natural xanthone from Gentianopsis paludosa Ma, in human promyelocytic leukemia cell line HL-60 cells.
    Ding L; Liu B; Qi LL; Zhou QY; Hou Q; Li J; Zhang Q
    Toxicol In Vitro; 2009 Apr; 23(3):408-17. PubMed ID: 19344684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of telomerase and cyclooxygenase-2 in PDGF and FGF inhibition of C2-ceramide-induced apoptosis.
    Chien CC; Shen SC; Yang LY; Wu CY; Liau JS; Chen YC
    J Cell Physiol; 2009 Feb; 218(2):405-15. PubMed ID: 18932216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.